| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Jun―17 |
Using PEGylated antigen-expressing extracellular vesicles to accomplish splenic B cell-targeted antigen delivery for induction of antibodies against SARS-CoV-2 spike protein |
Sherif E. Emam, Nehal E. Elsadek, Haruka Takata, Hidenori Ando, Tatsuhiro Ishida |
| 2 |
[GO] |
2025―Jan―30 |
A spleen-targeted vaccine for SARS-CoV-2 - inducting neutralizing antibodies in mice |
Taro Shimizu, Shunji Abe, Yoshino Kawaguchi, Haruka Takata, Hidenori Ando, Tatsuhiro Ishida |
| 3 |
[GO] |
2024―Jun―15 |
Minimal involvement of P-gp and BCRP in oral absorption of ensitrelvir, an oral SARS-CoV-2 3C-like protease inhibitor, in a non-clinical investigation |
Ryosuke Watari, Naomi Tamura, Shinpei Yoshida, Yasuto Kido, Takanobu Matsuzaki |
| 4 |
[GO] |
2023―Sep―23 |
Utility of coproporphyrin-I determination in first-in-human study for early evaluation of OATP1B inhibitory potential based on investigation of ensitrelvir, an oral SARS-CoV-2 3C-like protease inhibitor |
Ryosuke Watari, Hiromi Sawada, Hiroshi Hashimoto, Yasuyuki Kasai, Ryoko Oka, Ryosuke Shimizu, Takanobu Matsuzaki |
| 5 |
[GO] |
2023―Aug―16 |
Improving the Safety of Clinical Management of COVID-19 Patients Receiving Aminoglycosides and Parenteral Nutrition: Y-site Compatibility Studies |
Aleksandra Gostyńska, Katarzyna Dettlaff, Anna Jelińska, Maciej Stawny |
| 6 |
[GO] |
2023―Aug―04 |
Self-Assembly Properties of an Amphiphilic Phosphate Ester Prodrug Designed for the Treatment of COVID-19 |
Matthew N. O'Brien Laramy, Padmavani Bezawada, Reto Horst, Rohit Jaini, Jonathan Lillis, Yizhou Liu, et al. (+7) Suman Luthra, Bao Nguyen, Nandini Patel, Smita Soni, Bradley P. Sullivan, Andrew Thiel, Martyn D. Ticehurst |
| 7 |
[GO] |
2023―Feb―02 |
An overview of current accomplishments and gaps of COVID-19 vaccine platforms and considerations for next generation vaccines |
Akanksha Kale, Amitabh Gaur, Ipshita Menon, Narendra Chirmule, Priyal Bagwe, Rayan Jawa, et al. (+4) Sharon Vijayanand, Smital Patil, Surekha Suresh, Vibha Jawa |
| 8 |
[GO] |
2023―Feb―02 |
Immunogenicity evaluation of thermostable microparticles entrapping receptor binding domain of SARS-CoV-2 by single point administration |
Rahul Ahuja, Sudeepa Srichandan, Jairam Meena, Bichitra Kumar Biswal, Amulya K. Panda |
| 9 |
[GO] |
2022―Nov―02 |
Basis to Aid Crisis: Favipiravir Oral Solution for Hospital Compounding During COVID-19 Drug Shortage |
Bodin Tuesuwan, Wunlapa Mueannoom, Promporn Jamnongtanachot, Ariya Khunvichai, Chiravi Pavitrapok, Kawinthida Wongpakdee, et al. (+3) Supasil Sra-ium, Nithi Mahanonda, Vorasit Vongsutilers |
| 10 |
[GO] |
2022―Sep―18 |
The Race to Develop the Pfizer-BioNTech COVID-19 Vaccine: From the Pharmaceutical Scientists’ Perspective |
Lavinia M Lewis, Advait V Badkar, David Cirelli, Rodney Combs, Thomas F Lerch |
| 11 |
[GO] |
2022―Jun―09 |
Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment |
Gokben Sahin, Ozlem Akbal-Dagistan, Meltem Culha, Aybige Erturk, Nur Sena Basarir, Serap Sancar, Ayca Yildiz-Pekoz |
| 12 |
[GO] |
2021―Mrz―06 |
Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2 |
K. Abraham Peele, Vikas Kumar, Shraddha Parate, Krupanidhi Srirama, Keun Woo Lee, T.C. Venkateswarulu |
| 13 |
[GO] |
2020―Nov―26 |
Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective |
Simone Perazzolo, Linxi Zhu, Weixian Lin, Alexander Nguyen, Rodney JY. Ho |
| 14 |
[GO] |
2020―Nov―23 |
The science is there: key considerations for stabilizing viral vector-based Covid-19 vaccines |
Daan J.A. Crommelin, David B. Volkin, Karin H. Hoogendoorn, Anthony S. Lubiniecki, Wim Jiskoot |
| 15 |
[GO] |
2020―Nov―17 |
Warp-speed Covid-19 Vaccine development: beneficiaries of maturation in biopharmaceutical technologies and public-private partnerships |
Rodney JY. Ho |
| 16 |
[GO] |
2020―Sep―04 |
Development of a minimal physiologically-based pharmacokinetic model to simulate lung exposure in humans following oral administration of ivermectin for COVID-19 drug repurposing |
Brian Jermain, Patrick O. Hanafin, Yanguang Cao, Adrian Lifschitz, Carlos Lanusse, Gauri Rao |
